Benzinga’s Top Ratings Upgrades, Downgrades For January 4, 2023
Upgrades UBS upgraded the previous rating for Trane Technologies PLC (NYSE:TT) from Neutral to Buy. For the third…
This Pneumococcal Vaccine Player Is The Top Pick For 2023 For This Analyst
Vaxcyte Inc (NASDAQ:PCVX) is Needham’s top pick for 2023 and has been added to the Needham Conviction list and…
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Valneva SE (NASDAQ:VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The…
Drugmakers To Raise Prices On At Least 350 Drugs In U.S. In January
Drugmakers including Pfizer Inc PFE.N, GlaxoSmithKline PLC GSK.L, Bristol Myers Squibb BMY.N, AstraZeneca PLC AZN.L and Sanofi SA SASY.PA plan to raise prices in the United States on
New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows
A study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's (NYSE: PFE) oral COVID-19 pill.
Peering Into Pfizer’s Recent Short Interest
Pfizer's (NYSE:PFE) short percent of float has fallen 8.04% since its last report. The company recently reported that it has 58.02 million shares sold short, which is 1.03% of all regular shares that are available for trading.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Pfizer Announces Top-Line Results From Phase 3 Study Of Hemophilia B Gene Therapy Candidate; Study Met Primary Endpoint
The BENEGENE-2 study met its primary endpoint of non-inferiority and superiority in the annualized bleeding rate (ABR) of total bleeds post-fidanacogene elaparvovec infusion versus prophylaxis regimen with Factor IX
Coronavirus Omicron Subvariant BA.5 Surging in China May Be Evolving to Attack the Brain, Researchers Say
-South China Morning Post
https://www.scmp.com/news/china/science/article/3204807/coronavirus-omicron-ba5-subvariant-may-cause-more-damage-not-less-study?module=live&pgtype=homepage